Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion To Normal Heart Rhythm In Acute Atrial Fibrillation Patients

Astellas Pharma US, Inc. announced that the investigational agent vernakalant hydrochloride increased conversion to normal heart rhythm (sinus rhythm, or SR) in patients with atrial fibrillation (AF) treated within 48 hours of the onset of symptoms. AF is a serious condition characterized by an irregular heart rhythm and a high heart rate, and frequently leads to emergency department visits. [click link for full article]

More: continued here

Filed under: Cardiovascular on October 11th, 2007